Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
about
Prevention of mother-to-child transmission of HIV: cost-effectiveness of antiretroviral regimens and feeding options in RwandaResource allocation and priority setting of HIV/AIDS interventions: addressing the generalized epidemic in sub-Saharan AfricaAntiretrovirals for reducing the risk of mother-to-child transmission of HIV infectionAntiretrovirals for reducing the risk of mother-to-child transmission of HIV infectionResearch translation to inform national health policies: learning from multiple perspectives in UgandaCost-effectiveness of models for prevention of vertical HIV transmission - voluntary counseling and testing and choices of drug regimenCost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country--the case of TanzaniaHIV Testing Services in Africa: Are They Sustainable?Global impact of human immunodeficiency virus and AIDS.Global discourses and experiential speculation: Secondary and tertiary graduate Malawians dissect the HIV/AIDS epidemicThe Demand for, and Impact of, Learning HIV StatusThe cost-effectiveness of preventing mother-to-child transmission of HIV in low- and middle-income countries: systematic reviewHIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries.Cost-effectiveness of rapid syphilis screening in prenatal HIV testing programs in Haiti.Combining evidence and values in priority setting: testing the balance sheet method in a low-income countryOutputs, cost and efficiency of public sector centres for prevention of mother to child transmission of HIV in Andhra Pradesh, India.Perinatal HIV transmission and the cost-effectiveness of screening at 14 weeks gestation, at the onset of labour and the rapid testing of infants.Protein adducts as prospective biomarkers of nevirapine toxicity.Couples' voluntary counselling and testing and nevirapine use in antenatal clinics in two African capitals: a prospective cohort study.Role of traditional birth attendants in preventing perinatal transmission of HIV.Interventions aimed at decreasing the risk of mother-to-child transmission of HIV infection.The cost-effectiveness of different feeding patterns combined with prompt treatments for preventing mother-to-child HIV transmission in South Africa: estimates from simulation modeling.Clinical uses of non-nucleoside reverse transcriptase inhibitors.Sensitivity and specificity of human immunodeficiency virus rapid serologic assays and testing algorithms in an antenatal clinic in Abidjan, Ivory Coast.Determinants of male involvement in the prevention of mother-to-child transmission of HIV programme in Eastern Uganda: a cross-sectional survey.Nevirapine: a review of its use in the prevention and treatment of paediatric HIV infection.Economic evaluation of communicable disease interventions in developing countries: a critical review of the published literature.Assessing the efficiency of mother-to-child HIV prevention in low- and middle-income countries using data envelopment analysis.HIV chemotherapy.The 50th anniversary of the Declaration of Helsinki: progress but many remaining challenges.Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.Lack of effect from a previous single dose of nevirapine on virologic and immunologic responses after 6 months of antiretroviral regimens containing either efavirenz or lopinavir-ritonavir.Is antenatal syphilis screening still cost effective in sub-Saharan AfricaEvaluating Cost-effectiveness of Interventions That Affect Fertility and Childbearing: How Health Effects Are Measured Matters.Use of DALYs in economic analyses on interventions for infectious diseases: a systematic reviewClinical utility of current NNRTIs and perspectives of new agents in this class under development.Maternal malaria and perinatal HIV transmission, western Kenya.Sensitive oligonucleotide ligation assay for low-level detection of nevirapine resistance mutations in human immunodeficiency virus type 1 quasispeciesSojourn in South Africa(C2) Saliva, breast milk, and mucosal fluids in HIV transmission.
P2860
Q21034187-75E0A7CA-51CF-4F14-A89E-E1DBF394276EQ22252890-F7E33524-01A9-48EB-AA4C-A5BAE74CB5D6Q24235500-4DEF7A49-3377-4221-91B7-B6E8B45C0EC9Q24243146-62958A28-47D7-4F20-A3B1-0BEDA0887394Q24634420-20DB94D8-01EA-417F-9E4B-86891425239DQ24815606-40725F50-0984-4BF0-BF4C-E714D37610CCQ28219296-24FD0D7E-D2BC-42F7-BC2C-548970D60331Q30248542-C0705860-6983-4EE4-9876-DCA4F9D90A61Q30328098-6D65E879-A92C-43F1-82F2-563A9D921D3CQ30395811-22FA8611-9F95-4B9F-A475-D37374325A80Q30431885-8AE85E06-7AD8-4DAA-95E6-4EF7AA1E192DQ30498267-F31C53D6-0D2E-47AC-80CC-3BA9BCAE0A90Q31118706-FB303D6C-E30A-458C-B523-F68A5F617B3BQ33286065-84607A72-AC30-4D7E-916C-78B2264A4ED9Q33300156-1923F38C-D88C-4E01-A845-A83FEDCAE7A2Q33317430-4D33E4F4-DFD6-49D3-89A0-99A2A23C3851Q33396762-AA2CB3A3-0B2F-4291-97FB-B3677C6AA6ADQ33681307-656AC436-5F01-4E74-A1CA-7A06C9B347D1Q33776923-79128F86-EEC7-460B-ABB0-B295CD6B2198Q33808843-E31D1338-90BF-466B-A07F-0433972F40F2Q33906773-59B63643-C315-4048-A017-106D02093E38Q33940190-EDB1AEBC-4671-4B6E-80CB-7E7432F64216Q33966241-8D31C20E-90DF-4E03-9D84-DA06ACC5417AQ33972240-EB7341EE-6055-4645-BBB3-58712AF2C62EQ34035944-54CA6669-469B-406F-80C0-33691CE747C0Q34055828-7598BA4B-02EF-40BD-A0F3-504340870CBEQ34118278-6C76DE65-0370-4F57-85D9-21A4C8357C77Q34165971-1C575FA7-1BD6-4854-A404-C0BB7FFF7E13Q34223088-5EADA984-3A45-48BB-89A0-FF051F240090Q34373442-DAC98851-73CC-422F-AF78-58423D041AB5Q34546965-DC18E8B4-BCF1-43CE-9437-DC2D07062D83Q34679736-204DE3D6-FA4D-466E-AEC0-E78F55F38A0BQ35530964-C5A6C04D-CE7A-4E70-8D05-2627B59EAB72Q35564876-0A138A0F-47C3-40AE-AE31-0A9ED4BF48B1Q35686520-FCDD8F6D-16D6-4825-9D7D-E6BAD0B3A136Q35842270-1529A14E-6C29-41A5-AD9B-D04F3EB900A3Q35880187-8C1F066B-0675-4FF5-8036-F6A2BC5F2DB6Q35947480-17653C1D-0924-4E0D-97F2-92F602AD76F5Q36405641-63BDE4EE-8AB9-46AD-8E8F-E242C711F04FQ36467686-9BC06CA6-108A-448E-81D7-095ABE9463BF
P2860
Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Cost effectiveness of single-d ...... mission in sub-Saharan Africa.
@en
Cost effectiveness of single-d ...... mission in sub-Saharan Africa.
@nl
type
label
Cost effectiveness of single-d ...... mission in sub-Saharan Africa.
@en
Cost effectiveness of single-d ...... mission in sub-Saharan Africa.
@nl
prefLabel
Cost effectiveness of single-d ...... mission in sub-Saharan Africa.
@en
Cost effectiveness of single-d ...... mission in sub-Saharan Africa.
@nl
P2093
P921
P1433
P1476
Cost effectiveness of single-d ...... mission in sub-Saharan Africa.
@en
P2093
E Marseille
J B Jackson
M G Fowler
P304
P356
10.1016/S0140-6736(99)80009-9
P407
P577
1999-09-01T00:00:00Z